OncoSil Medical (ASX:OSL) has requested a trading halt on its securities. This move is in anticipation of an upcoming announcement concerning a capital raise. The trading halt, in accordance with ASX Listing Rule 17.1, will remain until the announcement or the beginning of trading on October 28, 2024.
OncoSil Medical (ASX:OSL) has placed a trading halt on its securities as it prepares to announce a capital raise. This decision aligns with ASX Listing Rule 17.1, emphasizing the company's adherence to regulatory standards. The halt will last until the announcement is made or until trading resumes on October 28, 2024. OncoSil's move suggests strategic planning for securing additional funds potentially needed for its operations or growth initiatives. The company remains transparent and compliant, as indicated by their communication with ASX Compliance.
The halt is requested pending an announcement regarding a capital raise. The company is not aware of any reason why the trading halt should not be granted nor any other information necessary to inform the market about the trading halt.